Francesco Ravera

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 07, 2025
Applications, challenges and future directions of artificial intelligence in cardio-oncology.

Francesco Ravera, Nicolò Gilardi, Alberto Ballestrero

|Jan 15, 2025
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.

Andrea Ceccardi, Martina Dameri, Francesco Ravera

Pageof 1